Treatment of newly diagnosed moderate or severe chronic graft-versus-host disease with prednisone and everolimus (PredEver first): a prospective multicenter phase IIA study

MLA

Ayuk, Francis, et al. “Treatment of Newly Diagnosed Moderate or Severe Chronic Graft-versus-Host Disease with Prednisone and Everolimus (PredEver First): A Prospective Multicenter Phase IIA Study.” Bone Marrow Transplantation, no. Preprints, Jan. 2024, pp. 1–5. EBSCOhost, https://doi.org/10.1038/s41409-024-02289-0.

APA

Ayuk, F., Wagner-Drouet, E.-M., Wolff, D., von Huenerbein, N., von Pein, U.-M., Klyuchnikov, E., von Harsdorf, S., Koenecke, C., Sayer, H., & Kröger, N. (2024). Treatment of newly diagnosed moderate or severe chronic graft-versus-host disease with prednisone and everolimus (PredEver first): a prospective multicenter phase IIA study. Bone Marrow Transplantation, Preprints, 1–5. https://doi.org/10.1038/s41409-024-02289-0

Chicago

Ayuk, Francis, Eva-Maria Wagner-Drouet, Daniel Wolff, Natascha von Huenerbein, Ute-Marie von Pein, Evgeny Klyuchnikov, Stephanie von Harsdorf, Christian Koenecke, Herbert Sayer, and Nicolaus Kröger. 2024. “Treatment of Newly Diagnosed Moderate or Severe Chronic Graft-versus-Host Disease with Prednisone and Everolimus (PredEver First): A Prospective Multicenter Phase IIA Study.” Bone Marrow Transplantation, no. Preprints (January): 1–5. doi:10.1038/s41409-024-02289-0.